Claris Biotherapeutics, Inc.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Earlier SEC source: 0001809726-26-000003 · Later SEC source: 0001809726-26-000004

Filings by year

• 20252 filings
• 20262 filings

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (4)

• 0001809726-26-000004

  D/A · Aug 12, 2026 · Biotechnology

  Offering: $121,477,910

  Sold: $55,737,646

  Compared with 0001809726-26-000003:

  • No changes in the four compared fields.
• 0001809726-26-000003

  D · Aug 7, 2026 · Biotechnology

  Offering: $121,477,910

  Sold: $55,737,646

  Compared with 0001809726-25-000004:

  • Reported offering amount: $2,300,000 → $121,477,910
  • Reported amount sold: $2,300,000 → $55,737,646
  • Reported investor count: Unavailable → 14
• 0001809726-25-000004

  D · Sep 22, 2025 · Biotechnology

  Offering: $2,300,000

  Sold: $2,300,000

  Compared with 0001809726-25-000001:

  • Reported offering amount: $3,300,000 → $2,300,000
  • Reported amount sold: $3,299,999 → $2,300,000
• 0001809726-25-000001

  D · Mar 7, 2025 · Biotechnology

  Offering: $3,300,000

  Sold: $3,299,999